Evidence Synthesis
ODYCORP has ended a quarterly period with a 28.7% gross margin, down from 39.27%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 4 Sept 2026, 13:19
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
ODYCORP has ended a quarterly period with a 28.7% gross margin, down from 39.27%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 28.7 % | 39.27 | ▼ |
| MARGINAL_OPERATING_LEVERAGE | 39.27 % | 9.25 | ▲ |
| REVENUE_GROWTH_YOY | 118.4 % | — | - |
| PRICE_CHANGE_PERCENT | 8.741 % | — | - |
| DAILY_VOLUME | 5,699 shares | 37,477 | ▼ |
| CLOSE_PRICE | 7.34 INR | 6.75 | ▲ |